Researchers have identified a therapeutic target that could lead to more effective treatment of glaucoma.

Registrations have opened for the Australasian Society of Cataract and Refractive Surgeons annual conference to be held in Port Douglas from 26–29 July.

The availability in Australia of pegcetacoplan injection (Syfovre) – the first-in-class treatment for geographic atrophic age-related macular degeneration (AMD) – is a step closer,

Optos is offering one-on-one demonstrations of its optomap device, for Sydney- based eye health professionals keen to incorporate the ultra-widefield retinal imaging technology into